Leppik R A
CSIRO Division of Food Research, Meat Research Laboratory, Queensland, Australia.
J Gen Microbiol. 1989 Jul;135(7):1979-88. doi: 10.1099/00221287-135-7-1979.
Eleven transposon mutant strains affected in bile acid catabolism were each found to form yellow, muconic-like intermediates from bile acids. To characterize these unstable intermediates, media from the growth of one of these mutants with deoxycholic acid was treated with ammonia, then the crude product was methylated with diazomethane. Four compounds were subsequently isolated; spectral evidence suggested that they were methyl 12 alpha-hydroxy-3-oxo-23,24-dinorchola-1,4-dien-22-oate, methyl 4-aza-12 beta-hydroxy-9(10)-secoandrosta-1,3,5-triene-9,17-dione-3-carboxyl ate, 4-aza-9 alpha, 12 beta-dihydroxy-9(10)-secoandrosta-1,3,5-trien-17-one-3- methyl carboxylate and 4 alpha-[3'-propionic acid]-5-amino-7 beta-hydroxy-7 alpha beta-methyl- 3a alpha, 4,7,7a-tetrahydro-1-indanone-delta-lactam. It is proposed that the mutants are blocked in the utilization of such muconic-like compounds as the 3,12 beta-dihydroxy-5,9,17-trioxo-4(5),9(10)- disecoandrostal (10),2-dien-4-oic acid formed from deoxycholic acid. A further mutant was examined, which converted deoxycholic acid to 12 alpha-hydroxyandrosta-1,4-dien-3,17-dione, but accumulated yellow products from steroids which lacked a 12 alpha-hydroxy function, such as chenodeoxycholic acid. The products from the latter acid were treated as above; spectral evidence suggested that the two compounds isolated were methyl 4-aza-7-hydroxy-9(10)-secoandrosta-1,3,5- triene-9,17-dione-3-carboxylate and 4 alpha-[1'alpha-hydroxy-3'-propionic acid]-5-amino-7a beta-methyl-3a alpha,4,7,7a-tetrahydro-1-indanone-delta-lactam.
研究发现,11种在胆汁酸分解代谢中受影响的转座子突变菌株均能从胆汁酸中形成黄色的、类粘康酸中间体。为了表征这些不稳定的中间体,将其中一个突变体与脱氧胆酸一起生长的培养基用氨处理,然后用重氮甲烷将粗产物甲基化。随后分离出四种化合物;光谱证据表明它们是12α-羟基-3-氧代-23,24-二降胆甾-1,4-二烯-22-酸甲酯、4-氮杂-12β-羟基-9(10)-开环雄甾-1,3,5-三烯-9,17-二酮-3-羧酸甲酯、4-氮杂-9α,12β-二羟基-9(10)-开环雄甾-1,3,5-三烯-17-酮-3-甲基羧酸甲酯和4α-[3'-丙酸]-5-氨基-7β-羟基-7αβ-甲基-3aα,4,7,7a-四氢-1-茚酮-δ-内酰胺。有人提出,这些突变体在利用诸如由脱氧胆酸形成的3,β-二羟基-5,9,17-三氧代-4(5),9(10)-二开环雄甾-1(0),2-二烯-4-酸这样的类粘康酸化合物方面受阻。对另一个突变体进行了研究,该突变体将脱氧胆酸转化为12α-羟基雄甾-1,4-二烯-3,17-二酮,但从缺乏12α-羟基功能的类固醇(如鹅脱氧胆酸)中积累黄色产物。将后一种酸产生的产物按上述方法处理;光谱证据表明分离出的两种化合物是4-氮杂-7-羟基-9(10)-开环雄甾-1,3,5-三烯-9,17-二酮-3-羧酸甲酯和4α-[1'α-羟基-3'-丙酸]-5-氨基-7aβ-甲基-3aα,4,7,7a-四氢-1-茚酮-δ-内酰胺。